Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05876858 · ClinicalTrials.gov registry record · Early Phase 1

EXPLORER Total Body PET/CT Imaging for Myofascial Pain

A Early Phase 1 study of Myofascial Pain, sponsored by University of California, Davis.

Active
Registry status
Early Phase 1
Development phase
53
Enrollment target
1
Study location

NCT05876858 is a Early Phase 1 study of Myofascial Pain that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 53 participants, below the 67-participant average among 8 other Myofascial Pain trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05876858, a Early Phase 1 study of Myofascial Pain, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metabolism, perfusion, and fatty infiltration.

Conditions Studied

Interventions

  • DRUG 18F-FDG
  • DRUG 11C-butanol

Study Locations (1)

California

  • University of California Davis Health - Sacramento

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-06-13
Est. Completion 2027-09
Phase Early Phase 1

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT05876858

The ClinicalTrials.gov registry entry for NCT05876858 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 8 other Myofascial Pain trials with a reported enrollment target (21% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myofascial Pain appearing as the primary indexed condition, and to 2 interventions - of which 18F-FDG is the first listed.

NCT05876858 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05876858 about?

NCT05876858 is a clinical study titled "EXPLORER Total Body PET/CT Imaging for Myofascial Pain". The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metaboli...

What is the current status of trial NCT05876858?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 53 participants. The study started on 2023-06-13. Estimated completion is 2027-09.

What conditions does trial NCT05876858 study?

This clinical trial studies the following conditions: Myofascial Pain.

What interventions are being tested in trial NCT05876858?

The interventions under investigation include: 18F-FDG (DRUG), 11C-butanol (DRUG).

Who is sponsoring clinical trial NCT05876858?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05876858 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myofascial Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.